Supplementary Tables 1 - 5 from Nottingham Clinico-Pathological Response Index (NPRI) after Neoadjuvant Chemotherapy (Neo-ACT) Accurately Predicts Clinical Outcome in Locally Advanced Breast Cancer
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Tables 1 to 5. Table (S1): Clinico-pathological characteristics of all three individual cohorts and the sum of all three together. Table (S2): Summery of pathological features that have been reviewed Table (S3): Univariate and multivariate backward step-wise analysis for factors associated with disease free survival (DFS) in the training cohort. Table (S4): Summery of the code system that has been used for calculation of Nottingham clinico-pathological response index (NPRI) Table (S5): Univariate analysis for clinicopathological features associated with disease free survival (DFS) and breast cancer specific survival (BCSS) in the training, internal and external validation cohorts.
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362398276